Viewing StudyNCT00101985



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00101985
Status: COMPLETED
Last Update Posted: 2015-04-13
First Post: 2005-01-18

Brief Title: Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome IBS
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Irritable Colon
Keywords:
Name View
Qol View
Quality of Life View
Irritable bowel syndrome View
IBS View
SB223412 View